Aceto Corp. Company Profile (NASDAQ:ACET)

About Aceto Corp.

Aceto Corp. logoAceto Corporation (Aceto) is engaged in marketing, sales and distribution of finished dosage form generic pharmaceuticals, nutraceutical products, pharmaceutical active ingredients and intermediates, specialty performance chemicals inclusive of agricultural intermediates and agricultural protection products. The Company's business is organized along product lines into three segments: Human Health, Pharmaceutical Ingredients and Performance Chemicals. The Human Health segment includes finished dosage form generic drugs and nutraceutical products. The Pharmaceutical Ingredients segment has two product groups: Active Pharmaceutical Ingredients (APIs) and Pharmaceutical Intermediates. The Performance Chemicals segment includes specialty chemicals and agricultural protection products. The Company has operations in China, Germany, France, the Netherlands, Singapore, India, Hong Kong, Philippines, the United Kingdom and the United States.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Chemicals - Major Diversified
  • Sub-Industry: Trading Companies & Distributors
  • Exchange: NASDAQ
  • Symbol: ACET
  • CUSIP: 00444610
Key Metrics:
  • Previous Close: $25.39
  • 50 Day Moving Average: $24.79
  • 200 Day Moving Average: $22.85
  • Trailing P/E Ratio: 18.11
  • Foreward P/E Ratio: 15.05
  • P/E Growth: 0.80
  • Market Cap: $754.71M
  • Outstanding Shares: 29,585,000
  • Beta: 1.4
Additional Links:
Companies Related to Aceto Corp.:

Analyst Ratings

Consensus Ratings for Aceto Corp. (NASDAQ:ACET) (?)
Ratings Breakdown: 1 Buy Rating
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $30.00 (17.23% upside)

Analysts' Ratings History for Aceto Corp. (NASDAQ:ACET)
DateFirmActionRatingPrice TargetDetails
3/30/2016First AnalysisInitiated CoverageOverweight$30.00View Rating Details
7/16/2015Craig HallumInitiated CoverageBuy$30.00View Rating Details
12/29/2014Singular ResearchBoost Price TargetBuy$24.00 -> $27.00View Rating Details
(Data available from 8/25/2014 forward)


Earnings History for Aceto Corp. (NASDAQ:ACET)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
8/25/2016Q416$0.39$146.71 millionListenView Earnings Details
5/5/2016Q3$0.39$0.42$150.07 million$157.90 millionViewListenView Earnings Details
2/4/2016Q2$0.30$0.36$132.71 million$131.70 millionViewListenView Earnings Details
11/5/2015Q116$0.34$0.37$139.89 million$133.50 millionViewListenView Earnings Details
9/10/2015Q415$0.31$0.48$146.68 million$146.60 millionViewListenView Earnings Details
5/7/2015Q3$0.29$0.34$140.00 million$145.80 millionViewListenView Earnings Details
2/5/2015Q115$0.26$0.28$130.00 million$13.00 millionViewListenView Earnings Details
11/6/2014Q414$0.29$0.23$146.40 million$130.80 millionViewListenView Earnings Details
9/4/2014Q314$0.17$0.21$134.23 million$139.60 millionViewListenView Earnings Details
5/8/2014Q214$0.28$0.19$136.70 million$124.83 millionViewListenView Earnings Details
2/7/2014Q114$0.24$0.24$147.02 million$116.50 millionViewListenView Earnings Details
8/28/2013Q4 2013$0.20$0.19$113.10 million$123.10 millionViewListenView Earnings Details
5/9/2013Q3 2013$0.26$0.34$128.56 million$150.90 millionViewListenView Earnings Details
11/8/2012Q113$0.19$0.18$110.85 million$111.70 millionViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for Aceto Corp. (NASDAQ:ACET)
Current Year EPS Consensus Estimate: $1.5 EPS
Next Year EPS Consensus Estimate: $1.7 EPS
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20163$0.35$0.40$0.37
Q2 20162$0.39$0.42$0.41
Q3 20161$0.39$0.39$0.39
Q4 20162$0.36$0.37$0.37
Q1 20172$0.37$0.43$0.40
Q2 20172$0.40$0.49$0.45
Q3 20172$0.40$0.47$0.44
Q4 20171$0.41$0.41$0.41
(Data provided by Zacks Investment Research)


Current Dividend Information for Aceto Corp. (NASDAQ:ACET)
Annual Dividend:$0.24
Dividend Yield:0.94%
Payout Ratio:17.02% (Based on Trailing 12 Months of Earnings)
16.00% (Based on Current Year Consensus EPS Estimate)
14.12% (Based on Next Year Consensus EPS Estimate)

Dividend History for Aceto Corp. (NASDAQ:ACET)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading History for Aceto Corp. (NASDAQ:ACET)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
7/19/2016Satish SrinivasanCOOSell595$25.48$15,160.60View SEC Filing  
7/7/2016Frank DebenedittisVPSell3,275$23.34$76,438.50View SEC Filing  
7/6/2016Albert L EilenderChairmanSell7,690$22.53$173,255.70View SEC Filing  
7/6/2016Charles John AlaimoSVPSell3,639$22.41$81,549.99View SEC Filing  
7/6/2016Douglas A RothCFOSell6,770$22.72$153,814.40View SEC Filing  
7/6/2016Salvatore J Sr Guccione SrCEOSell10,945$23.25$254,471.25View SEC Filing  
7/6/2016Satish SrinivasanCOOSell3,250$22.80$74,100.00View SEC Filing  
7/6/2016Steven RogersVPSell3,275$22.50$73,687.50View SEC Filing  
6/7/2016Terry KippleyVPSell2,000$22.50$45,000.00View SEC Filing  
6/7/2016William N BrittonDirectorSell4,200$23.12$97,104.00View SEC Filing  
6/6/2016Frank DebenedittisVPSell6,810$22.63$154,110.30View SEC Filing  
6/6/2016Satish SrinivasanCOOSell3,497$22.69$79,346.93View SEC Filing  
5/31/2016Albert L EilenderChairmanSell9,881$22.21$219,457.01View SEC Filing  
5/26/2016Douglas A RothCFOSell7,000$22.16$155,120.00View SEC Filing  
3/10/2016Raymond BartoneSVPSell3,000$22.40$67,200.00View SEC Filing  
3/8/2016Hans C NoetzliDirectorSell6,500$22.91$148,915.00View SEC Filing  
3/2/2016Frank DebenedittisVPSell3,000$21.98$65,940.00View SEC Filing  
3/1/2016Steven RogersVPSell2,100$21.82$45,822.00View SEC Filing  
2/25/2016Albert L EilenderChairmanSell9,281$21.79$202,232.99View SEC Filing  
2/23/2016Charles John AlaimoSVPSell4,750$21.91$104,072.50View SEC Filing  
2/23/2016Douglas A RothCFOSell17,000$21.52$365,840.00View SEC Filing  
12/9/2015Satish SrinivasanCOOSell3,000$27.02$81,060.00View SEC Filing  
12/9/2015Terry KippleyVPSell1,550$27.06$41,943.00View SEC Filing  
12/8/2015Nicolas I ShackleySVPSell3,000$26.70$80,100.00View SEC Filing  
12/1/2015Charles John AlaimoSVPSell3,000$28.22$84,660.00View SEC Filing  
11/25/2015Hans C. NoetzliDirectorSell3,000$27.52$82,560.00View SEC Filing  
11/24/2015Steven RogersVPSell3,000$27.56$82,680.00View SEC Filing  
10/15/2015Albert L. EilenderChairmanSell8,155$28.90$235,679.50View SEC Filing  
9/10/2015Charles John AlaimoSVPSell1,620$22.14$35,866.80View SEC Filing  
9/10/2015Douglas A. RothCFOSell6,250$22.14$138,375.00View SEC Filing  
9/10/2015Frank DebenedittisVPSell2,553$22.14$56,523.42View SEC Filing  
9/10/2015Salvatore J. Sr Guccione, Sr.CEOSell9,386$22.14$207,806.04View SEC Filing  
7/2/2015Albert L EilenderChairmanSell10,938$24.20$264,699.60View SEC Filing  
7/2/2015Charles John AlaimoSVPSell2,998$24.19$72,521.62View SEC Filing  
7/2/2015Douglas A RothCFOSell5,748$24.19$139,044.12View SEC Filing  
7/2/2015Frank DebenedittisVPSell2,629$24.19$63,595.51View SEC Filing  
7/2/2015Salvatore J Sr Guccione SrCEOSell9,114$24.19$220,467.66View SEC Filing  
7/2/2015Satish SrinivasanCOOSell1,921$24.19$46,468.99View SEC Filing  
6/8/2015Raymond BartoneSVPSell5,000$24.44$122,200.00View SEC Filing  
6/3/2015Frank DebenedittisVPSell4,000$24.41$97,640.00View SEC Filing  
5/27/2015Charles John AlaimoSVPSell2,000$23.19$46,380.00View SEC Filing  
5/12/2015William N BrittonDirectorSell13,000$21.31$277,030.00View SEC Filing  
3/4/2015Douglas A RothCFOSell5,000$20.99$104,950.00View SEC Filing  
3/4/2015Natasha GiordanoDirectorSell2,164$20.92$45,270.88View SEC Filing  
2/12/2015Douglas A RothCFOSell6,000$19.91$119,460.00View SEC Filing  
2/10/2015Charles John AlaimoSVPSell2,000$20.15$40,300.00View SEC Filing  
12/9/2014Frank DebenedittisVPSell3,000$21.25$63,750.00View SEC Filing  
12/5/2014Douglas A RothCFOSell7,000$22.07$154,490.00View SEC Filing  
12/3/2014Terry KippleyVPSell1,950$21.35$41,632.50View SEC Filing  
12/2/2014Terry KippleyVPSell1,797$21.45$38,545.65View SEC Filing  
12/1/2014Satish SrinivasanCOOSell1,430$21.00$30,030.00View SEC Filing  
11/11/2014Charles John AlaimoSVPSell2,250$21.22$47,745.00View SEC Filing  
9/9/2014Douglas A RothCFOSell6,000$21.57$129,420.00View SEC Filing  
9/9/2014Natasha GiordanoDirectorSell1,453$21.94$31,878.82View SEC Filing  
9/9/2014Raymond BartoneSVPSell3,000$21.49$64,470.00View SEC Filing  
9/9/2014Steven RogersVPSell8,335$21.50$179,202.50View SEC Filing  
9/2/2014Albert L EilenderChairmanSell7,144$19.14$136,736.16View SEC Filing  
8/29/2014Hans C NoetzliDirectorSell2,000$18.85$37,700.00View SEC Filing  
8/15/2014Hans C NoetzliDirectorSell2,000$18.63$37,260.00View SEC Filing  
8/4/2014Albert L EilenderChairmanSell4,195$16.71$70,098.45View SEC Filing  
8/1/2014Hans C NoetzliDirectorSell2,000$16.67$33,340.00View SEC Filing  
7/25/2014Albert L EilenderChairmanSell2,450$17.63$43,193.50View SEC Filing  
7/3/2014Hans C NoetzliDirectorSell2,000$17.86$35,720.00View SEC Filing  
7/2/2014Albert L EilenderChairmanSell1,750$18.05$31,587.50View SEC Filing  
6/6/2014Charles John AlaimoSVPSell2,000$17.51$35,020.00View SEC Filing  
6/6/2014Natasha GiordanoDirectorSell1,160$17.28$20,044.80View SEC Filing  
6/6/2014Steven RogersVPSell2,333$17.58$41,014.14View SEC Filing  
6/4/2014Frank DebenedittisVPSell30,000$17.09$512,700.00View SEC Filing  
6/4/2014Nicolas I ShackleyInsiderSell1,000$17.29$17,290.00View SEC Filing  
6/2/2014Douglas A RothCFOSell6,500$17.10$111,150.00View SEC Filing  
6/2/2014Natasha GiordanoDirectorSell1,149$17.43$20,027.07View SEC Filing  
5/23/2014Natasha GiordanoDirectorSell1,128$17.91$20,202.48View SEC Filing  
5/21/2014Natasha GiordanoDirectorSell1,110$17.81$19,769.10View SEC Filing  
3/10/2014Terry KippleyVPSell3,817$19.17$73,171.89View SEC Filing  
2/14/2014Roger Weaving, Jr.SVPSell6,000$18.96$113,760.00View SEC Filing  
11/12/2013Roger Weaving, Jr.SVPSell14,605$19.03$277,933.15View SEC Filing  
9/6/2013Raymond BartoneSVPSell19,000$14.84$281,960.00View SEC Filing  
6/7/2013Roger Weaving JrVPSell4,420$13.02$57,548.40View SEC Filing  
6/6/2013Guillaume Saint-ClairVPSell15,332$13.01$199,469.32View SEC Filing  
6/4/2013Douglas A RothCFOSell30,000$13.31$399,300.00View SEC Filing  
6/4/2013Eis Jan VanDirectorSell9,000$13.39$120,510.00View SEC Filing  
5/24/2013Ronald GoldCOOSell25,000$11.71$292,750.00View SEC Filing  
5/22/2013Frank DebenedittisVPSell8,300$11.86$98,438.00View SEC Filing  
5/21/2013Frank DebenedittisVPSell7,867$12.00$94,404.00View SEC Filing  
5/17/2013Douglas A RothCFOSell20,200$11.31$228,462.00View SEC Filing  
5/17/2013Guillaume Saint-ClairVPSell2,250$11.15$25,087.50View SEC Filing  
5/15/2013Ronald GoldCOOSell55,000$11.23$617,650.00View SEC Filing  
5/14/2013David B RosenVPSell40,000$11.05$442,000.00View SEC Filing  
5/14/2013Roger Weaving JrSVPSell5,600$11.09$62,104.00View SEC Filing  
(Data available from 1/1/2013 forward)


Latest Headlines for Aceto Corp. (NASDAQ:ACET)
News IconGlucuronolactone Market Volume Forecast and Value Chain Analysis 2015-2025 (NASDAQ:ACET) - August 24 at 11:36 AM logo11:18 am Aceto launches Fluocinolone Acetonide Body Oil 0.01%, a generic version of Derma-Smoothe/FS body oil & Fluocinolone Acetonide Scalp Oil 0.01%, a generic version of Derma-Smoothe/FS scalp oil (NASDAQ:ACET) - August 23 at 3:16 PM logoACETO Subsidiary, Rising Pharmaceuticals, to launch Fluocinolone Acetonide Body Oil, 0.01%, and Fluocinolone Acetonide Scalp Oil, 0.01% (NASDAQ:ACET) - August 23 at 3:16 PM logoACETO Corporation Schedules Fourth Quarter & Fiscal 2016 Financial Results News Release and Conference Call (NASDAQ:ACET) - August 12 at 11:51 AM logoETF’s with exposure to Aceto Corp. : July 26, 2016 (NASDAQ:ACET) - July 26 at 12:38 PM logoACETO CORP : Change in Directors or Principal Officers, Financial Statements and Exhibits (form 8-K) (NASDAQ:ACET) - July 19 at 9:28 AM logoACETO CORP Files SEC form 8-K, Change in Directors or Principal Officers, Financial Statements and Exhibits (NASDAQ:ACET) - July 18 at 5:17 PM
News IconCHIEF EXECUTIVE OFFICER of Aceto Corporation (NASDAQ:ACET), Guccione Salvatore J Sr, sells 10,945 shares worth $254,420 (NASDAQ:ACET) - July 9 at 3:16 PM
News IconSENIOR VICE PRESIDENT of Aceto Corporation (NASDAQ:ACET), Alaimo Charles John, sells 3,639 shares worth $81,551 (NASDAQ:ACET) - July 9 at 11:24 AM logoTeligent Receives 2 FDA Approvals For Topical Prescription Portfolio (NASDAQ:ACET) - July 8 at 10:32 AM
News IconSenior Vice President of Aceto Corporation (NASDAQ:ACET), Bartone Raymond, sells 2,392 shares worth $53,605 (NASDAQ:ACET) - July 7 at 8:34 PM logoAceto Corp. – Value Analysis (NASDAQ:ACET) : July 5, 2016 (NASDAQ:ACET) - July 5 at 11:57 AM logoAceto Corp. breached its 50 day moving average in a Bullish Manner : ACET-US : July 4, 2016 (NASDAQ:ACET) - July 4 at 8:18 AM
News IconRecent research into the Ethyl 2-Methyl Aceto Acetate (CAS 609-14-3) Industry shared in new report (NASDAQ:ACET) - June 27 at 3:29 PM logoAceto Corp. breached its 50 day moving average in a Bullish Manner : ACET-US : June 24, 2016 (NASDAQ:ACET) - June 24 at 8:11 AM logoAceto Corp. breached its 50 day moving average in a Bearish Manner : ACET-US : June 13, 2016 (NASDAQ:ACET) - June 13 at 8:38 AM
News IconNew report examines the Global fluorescent brightening agents (FBAs) industry forecast to 2021 (NASDAQ:ACET) - June 4 at 3:18 PM logoAceto Corp. breached its 50 day moving average in a Bullish Manner : ACET-US : June 2, 2016 (NASDAQ:ACET) - June 2 at 8:03 AM logoETF’s with exposure to Aceto Corp. : May 26, 2016 (NASDAQ:ACET) - May 26 at 7:05 PM logoACETO to Present in June Conferences (NASDAQ:ACET) - May 23 at 4:46 PM
News IconRestaurant review: Authentic Italian food in Cheltenham cafe Mutina (NASDAQ:ACET) - May 21 at 1:53 PM
News IconAmalfi coast in danger of crumbling into sea (NASDAQ:ACET) - May 17 at 2:51 PM logoTeligent Gets FDA Approval For Triamcinolone Acetonide Ointment (NASDAQ:ACET) - May 16 at 10:02 AM
News IconItaly's Amalfi Coast under threat from land erosion as 'flying' lemon farmers dwindle (NASDAQ:ACET) - May 15 at 8:14 AM logoAceto Corp. :ACET-US: Earnings Analysis: Q3, 2016 By the Numbers (NASDAQ:ACET) - May 13 at 10:15 AM
News IconSOFTBALL: Sturgis West navigating toward playoffs (NASDAQ:ACET) - May 6 at 8:25 AM logoACETO Reports Fiscal 2016 Third Quarter Results (NASDAQ:ACET) - May 5 at 5:24 PM logoBenzocaine Market Trends and 2021 Future Growth Analysis (NASDAQ:ACET) - May 5 at 8:15 AM logoLearn Details of the Advances in Glucuronolactone Market Forecast and Segments, 2015-2025 (NASDAQ:ACET) - May 5 at 8:15 AM logoQ3 2016 Aceto Corp Earnings Release - After Market Close (NASDAQ:ACET) - May 5 at 7:07 AM logoETF’s with exposure to Aceto Corp. : May 3, 2016 (NASDAQ:ACET) - May 3 at 1:27 PM logoAceto Corp. breached its 50 day moving average in a Bearish Manner : ACET-US : May 2, 2016 (NASDAQ:ACET) - May 2 at 8:42 AM
News IconA lasting tribute (NASDAQ:ACET) - April 30 at 8:14 AM
News IconThai cooking class, food truck rodeo and more food events (NASDAQ:ACET) - April 27 at 9:39 AM logoACETO Corporation Schedules Third Quarter & Fiscal 2016 Financial Results News Release and Conference Call (NASDAQ:ACET) - April 21 at 8:55 AM logoACETO to Present at the Needham & Company Healthcare Conference (NASDAQ:ACET) - April 7 at 3:28 PM
News IconCalendar of Events Apr. 1 (NASDAQ:ACET) - April 5 at 1:49 PM logoHottest Wholesale Trade Stocks Now – ACET PRMW HBP MIC (NASDAQ:ACET) - March 31 at 2:34 PM logoCoverage initiated on Aceto by First Analysis Sec (NASDAQ:ACET) - March 31 at 5:44 AM logoBRIEF-Aceto corp says subsidiary, Rising Pharmaceuticals, to launch lithium carbonate extended-release tablets and metronidazole tablets (NASDAQ:ACET) - March 23 at 10:32 AM logoACETO Subsidiary, Rising Pharmaceuticals, to Launch Lithium Carbonate Extended-release Tablets and Metronidazole Tablets (NASDAQ:ACET) - March 23 at 9:42 AM logoAceto Corp. breached its 50 day moving average in a Bullish Manner : ACET-US : March 8, 2016 (NASDAQ:ACET) - March 8 at 8:04 AM
News IconDStrong’ comedy night raises thousands for Dorian’s Miracle (NASDAQ:ACET) - March 5 at 1:44 PM
News IconBürstner Viseo i 720 G (NASDAQ:ACET) - February 29 at 2:03 PM
News IconSt Albans gym becomes last tenant to leave former industrial works site (NASDAQ:ACET) - February 14 at 11:32 AM
News IconLuisa Miller review (Sydney Opera House) (NASDAQ:ACET) - February 12 at 12:12 PM logoIABC/Toronto selects IKEA Canada President Stefan Sjöstrand as 2015 Communicator of the Year (NASDAQ:ACET) - February 11 at 12:07 PM logoEdited Transcript of ACET earnings conference call or presentation 5-Feb-16 2:00pm GMT (NASDAQ:ACET) - February 8 at 4:43 PM logoAceto Corp. Earnings Analysis: Q2, 2016 By the Numbers (NASDAQ:ACET) - February 8 at 11:14 AM
News IconChinese dissidents in Thailand live in fear; 'no longer feel safe' (NASDAQ:ACET) - February 5 at 11:33 AM


Aceto Corp. (NASDAQ:ACET) Chart for Thursday, August, 25, 2016

Last Updated on 8/25/2016 by Staff